SAN CARLOS, Calif.--September 23, 2026--Glycomine, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to GLM101 for the treatment of phosphomannomutase 2 congenital...
Borah
Borah was formed in 2022 when the company Boragen was split into three separate companies, 5Metis, Borah and Reactive Biosciences.
